We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 14.89%
This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$817M
AUM Growth
-$36.2M
Cap. Flow
-$39.4M
Cap. Flow %
-4.82%
Top 10 Hldgs %
12.04%
Holding
1,060
New
418
Increased
118
Reduced
111
Closed
413

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$12.8M
2
CRM icon
Salesforce
CRM
+$9.18M
3
NKE icon
Nike
NKE
+$8.85M
4
DHR icon
Danaher
DHR
+$8.43M
5
AMZN icon
Amazon
AMZN
+$8.08M

Top Sells

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$17.9M
2
TSLA icon
Tesla
TSLA
+$16.6M
3
CVX icon
Chevron
CVX
+$15.3M
4
MDB icon
MongoDB
MDB
+$9.4M
5
FTNT icon
Fortinet
FTNT
+$8.82M

Sector Composition

Rank Sector Weight
1 Technology 22.57%
2 Consumer Discretionary 15.97%
3 Healthcare 14.57%
4 Industrials 11.33%
5 Financials 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPL
551
PPL Corp
PPL
$25.8B
$217K 0.03%
6,700
-30,100
-82% -$991K
MEI icon
552
Methode Electronics
MEI
$646M
$217K 0.03%
+18,442
New +$201K
SSYS icon
553
Stratasys
SSYS
$679M
$217K 0.03%
+24,360
New +$210K
TILE icon
554
Interface
TILE
$2.19B
$217K 0.03%
+8,893
New +$204K
CXW icon
555
CoreCivic
CXW
$3.38B
$211K 0.03%
+9,700
New +$178K
UBS icon
556
UBS Group
UBS
$168B
$211K 0.03%
+6,949
New +$220K
NVST icon
557
Envista
NVST
$4.36B
$210K 0.03%
10,900
-26,200
-71% -$518K
VIRT icon
558
Virtu Financial
VIRT
$5.92B
$210K 0.03%
+5,887
New +$202K
SEE
559
DELISTED
Sealed Air
SEE
$210K 0.03%
6,200
-8,417
-58% -$300K
VRNT
560
DELISTED
Verint Systems
VRNT
$209K 0.03%
+7,600
New +$190K
COLD icon
561
Americold
COLD
$4.28B
$208K 0.03%
+9,700
New +$235K
SSRM icon
562
SSR Mining
SSRM
$7.54B
$207K 0.03%
+29,801
New +$185K
HTZ icon
563
Hertz
HTZ
$766M
$205K 0.03%
+55,900
New +$202K
IBN icon
564
ICICI Bank
IBN
$107B
$203K 0.02%
+6,800
New +$205K
EC icon
565
Ecopetrol
EC
$33.8B
$203K 0.02%
+25,600
New +$206K
TU icon
566
Telus
TU
$15.2B
$202K 0.02%
+14,900
New +$230K
NTR icon
567
Nutrien
NTR
$35.3B
$201K 0.02%
+4,500
New +$214K
TRUP icon
568
Trupanion
TRUP
$1.32B
$201K 0.02%
+4,166
New +$214K
XNCR icon
569
Xencor
XNCR
$1.98B
$200K 0.02%
8,716
-2,100
-19% -$48.3K
HBM icon
570
Hudbay
HBM
$12.9B
$200K 0.02%
+24,657
New +$221K
SDGR icon
571
Schrodinger
SDGR
$1.48B
$199K 0.02%
+10,300
New +$200K
BCRX icon
572
BioCryst Pharmaceuticals
BCRX
$2.49B
$193K 0.02%
+25,700
New +$195K
MD icon
573
Pediatrix Medical
MD
$2.16B
$190K 0.02%
+14,500
New +$200K
AEHR icon
574
Aehr Test Systems
AEHR
$2.71B
$185K 0.02%
+11,100
New +$148K
VSTS icon
575
Vestis
VSTS
$1.66B
$184K 0.02%
12,100
-48,900
-80% -$736K

Similar funds

Bayesian Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Bayesian Capital Management held 1,060 positions worth $817M, down 4.2% from $853M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Bayesian Capital Management withdrew a net $39.4M in Q4 2024, closing 413 positions and reducing 111 holdings. Its most notable exit was Netflix, an estimated $17.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Bayesian Capital Management opened a new position in Amgen worth $11.2M.

  • Bayesian Capital Management's largest Q4 2024 buy was Amgen: 43,000 shares worth $11.2M.
  • Bayesian Capital Management added most to Nike in Q4 2024, an estimated $8.85M increase.
  • Bayesian Capital Management's biggest Q4 2024 reduction was Tesla, cutting an estimated $16.6M.
  • Bayesian Capital Management fully exited Netflix in Q4 2024, selling an estimated $17.9M.
  • Bayesian Capital Management's ten largest holdings make up 12% of its $817M portfolio in Q4 2024.
  • Bayesian Capital Management opened 418 new positions and closed 413 in Q4 2024.
  • Bayesian Capital Management's portfolio value fell 4.2% quarter-over-quarter to $817M.

Based on Bayesian Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.